Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health

This report looks at how pharmaceutical and medical device companies can create shared value in global health by addressing unmet health needs in low- and middle-income countries. Companies have already begun to reap business value and are securing competitive advantages in the markets of tomorrow

Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition

The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the concern that these mergers will concentrate the market for discovery and will therefore lead to fewer discoveries; and (2) the concern that merging large marketing, sales, and distribution forces will strengthen the hands of select pharmaceutical manufacturers and weaken downstream competition. Having considered potential dynamic effects in the industry and conducted a series of preliminary interviews with knowledgeable observers, though, this Article argues that neither of these common fears is systematically warranted. There are, however, potential dangers in market concentration at an intermediate stage during the discovery-to-development path: the stage for regulatory approval. These preliminary findings are a product of dramatic changes that are currently reshaping the structure of the pharmaceutical industry. This Article discusses how these structural changes contribute to the current merger wave, how dynamic responses by industry players in response to the merger wave mitigate the potential harm from competition, and how the political arena might still offer threats to market concentration

Analysis of the characteristics of traceability models for logistics processes in the pharmaceutical industry in Colombia

En la actualidad la gestión logística de procesos en el sector farmacéutico enfrenta retos asociados al seguimiento y trazabilidad de la información. Los sistemas de trazabilidad están diseñados para el seguimiento detallado de uno o varios productos a lo largo de la cadena de abastecimiento. A partir de los diferentes modelos de trazabilidad de información de la cadena de abastecimiento se pretende garantizar la calidad, manipulación y condiciones del producto, respecto a las regulaciones pertinentes. El presente artículo corresponde al análisis de las características de los modelos de trazabilidad para procesos logísticos en el sector farmacéutico en Colombia. El articulo presenta una base de conceptos y referencias que permiten identificar las características esenciales de la trazabilidad de la información dentro de una cadena de abastecimiento, a partir de la identificación de los modelos de trazabilidad hacia adelante, es decir tracking y de trazabilidad hacia atrás que corresponde a tracing, integrando características físicas de un producto como la temperatura, características técnicas, humedad, inspecciones, fecha de fabricación y fecha de vencimiento, asociadas al sector farmacéutico, con el fin de realizar controles a nivel normativo y de calidad de los productos y procesos logísticos.Currently, the logistics management of processes in the pharmaceutical sector faces challenges associated with the monitoring and traceability of information. Traceability systems are designed for detailed tracking of one or more products throughout the supply chain. Based on the different information traceability models of the supply chain, the aim is to guarantee the quality, handling and conditions of the product, with respect to the relevant regulations. This paper corresponds to the analysis of the characteristics of the traceability models for logistics processes in the pharmaceutical sector in Colombia. The article presents a base of concepts and references that allow to identify the essential characteristics of information traceability within a supply chain, from the identification of forward traceability models, that is, tracking and backward traceability that corresponds to tracing, integrating physical characteristics of a product such as temperature, technical characteristics, humidity, inspections, manufacturing date and expiration date, associated with the pharmaceutical sector, in order to carry out controls at the regulatory and quality level of the products and logistics processes.Especializació

Shared Value in Emerging Markets: How Multinational Corporations Are Redefining Business Strategies to Reach Poor or Vulnerable Populations

This report illuminates the enormous opportunities in emerging markets for companies to drive competitive advantage and sustainable impact at scale. It identifies how over 30 companies across multiple sectors and geographies design and measure business strategies that also improve the lives of underserved individuals

The WTO Decision on Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: A Solution to the Access to Essential Medicines Problem?

This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Journal of International Economic Law following peer review. The definitive publisher-authenticated version [DOI: 10.1093/jiel17.1.73] is available online at: http://jiel.oxfordjournals.org/content/7/1/73.full.pd

Facilitating Humanitarian Access to Pharmaceutical and Agricultural Innovation

Calls for intellectual property licensing strategies in the pharmaceutical and agricultural sectors that promote humanitarian access to product innovations for the benefit of the disadvantaged. Includes profiles of successful and promising strategies

Innovation in India and China : Challenges and Prospects in Pharmaceuticals and Biotechnology

India and China are important players in an evolving process of globalization of research and development (R&D). Focusing on pharmaceuticals and biotechnology industries, this paper analyses the challenges and prospects facing the two countries in global innovation. Large supplies of highly skilled professionals and well-established science and technology infrastructures are important assets for India and China in the era of globalization of R&D. At the same time, however, there is a concern that as globalization of R&D gathers steam, the poor in India, China and other developing countries are likely to be left out of the new innovations. A good example is the case of Indias pharmaceuticals industry. The leading Indian pharmaceutical firms have responded well to the challenge of a strict intellectual property rights (IPR) regime by increasing their R&D spending and, simultaneously, targeting their sales to the generic drugs markets in North America and Europe. But even as Indias top drug firms have been growing in technological capabilities and taking part in the globalization of pharmaceuticals R&D, they have also been shifting their focus away from the market for medicines for poor patients.India, China, innovation, pharmaceuticals, biotechnology

Predicting the Effects of News Sentiments on the Stock Market

Stock market forecasting is very important in the planning of business activities. Stock price prediction has attracted many researchers in multiple disciplines including computer science, statistics, economics, finance, and operations research. Recent studies have shown that the vast amount of online information in the public domain such as Wikipedia usage pattern, news stories from the mainstream media, and social media discussions can have an observable effect on investors opinions towards financial markets. The reliability of the computational models on stock market prediction is important as it is very sensitive to the economy and can directly lead to financial loss. In this paper, we retrieved, extracted, and analyzed the effects of news sentiments on the stock market. Our main contributions include the development of a sentiment analysis dictionary for the financial sector, the development of a dictionary-based sentiment analysis model, and the evaluation of the model for gauging the effects of news sentiments on stocks for the pharmaceutical market. Using only news sentiments, we achieved a directional accuracy of 70.59% in predicting the trends in short-term stock price movement.Comment: 4 page